SKAN Group AG (SKAN) AI Stock Analysis

• Market Cap: CHF1.28B
• Dividend Yield: 0.77%
• Average Volume (3M): 22.50K
• Price to Earnings (P/E): 78.9
• Beta (1Y): 1.00
• Revenue Growth: -7.74%
• EPS Growth: -58.06%
• Country: CH
• Employees: 1,377
• Sector: General
• Sector Strength: N/A
• Industry: Medical - Instruments & Supplies
• EPS (TTM): 0.72
• Shares Outstanding: 22,483,524
• 10 Day Avg. Volume: 19,367
• 30 Day Avg. Volume: 22,504
• PEG Ratio: -1.26
• Price to Book (P/B): 10.37
• Price to Sales (P/S): 3.56
• P/FCF Ratio: 56.51
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 1.36
• Revenue Forecast (FY): CHF392.90M

• Rating: 57 Neutral
• Price Target: CHF60.00 ▲(10.09% Upside)
• Action: Reiterated
• Date: 07/05/26

Positive Factors

High Gross Margins

Sustained gross margins near 70% indicate strong product-level economics and pricing power in contamination-control equipment. High margins support funding of R&D, service capabilities and product customization, creating durable profitability potential even if volumes fluctuate.

Negative Factors

Rising Leverage

Debt-to-equity jumping to ~1.15 from historically near 0.04–0.11 materially reduces financial flexibility. Higher leverage increases interest and refinancing risk, constraining ability to invest in growth or weather margin volatility, and magnifies downside if profitability does not recover.

SKAN Group AG Business Overview & Revenue Model

Company Description

SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company ...

Read more

SKAN Group AG is a global leader specializing in critical solutions for the pharmaceutical and chemical sectors, offering advanced isolators, cleanroom technologies, and decontamination processes across Asia, Europe, and the Americas. The company ...

How the Company Makes Money

SKAN primarily generates revenue by selling and delivering contamination-control equipment and integrated systems used in sterile pharmaceutical manufacturing (e.g., isolator-based solutions and related aseptic processing/containment systems). Rev...

Read more

SKAN primarily generates revenue by selling and delivering contamination-control equipment and integrated systems used in sterile pharmaceutical manufacturing (e.g., isolator-based solutions and related aseptic processing/containment systems). Rev...

SKAN Group AG Financial Statement Overview

Breakdown	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	333.33M	361.30M	320.02M	276.95M	234.26M
Gross Profit	230.31M	265.88M	234.08M	200.50M	170.11M
EBITDA	36.03M	59.68M	50.14M	40.15M	32.38M
Net Income	16.27M	38.80M	26.31M	18.99M	10.62M
Balance Sheet
Total Assets	481.08M	384.49M	373.45M	388.35M	331.92M
Cash, Cash Equivalents and Short-Term Investments	94.08M	61.71M	85.12M	135.98M	131.54M
Total Debt	131.47M	10.61M	6.49M	16.88M	15.27M
Total Liabilities	353.49M	181.92M	197.09M	222.76M	157.92M
Stockholders Equity	114.45M	196.16M	169.23M	157.30M	159.75M
Cash Flow
Free Cash Flow	21.01M	-7.09M	-26.60M	32.62M	-32.29M
Operating Cash Flow	64.11M	46.70M	8.70M	61.48M	10.32M
Investing Cash Flow	-130.91M	-69.06M	-17.35M	-76.42M	-11.02M
Financing Cash Flow	108.99M	-9.35M	-15.80M	-4.85M	67.48M

SKAN Group AG Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 54.50
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:SKAN, the sentiment is Positive. The current price of 54.5 is above the 20-day moving average (MA) of 53.29, above the 50-day MA of 50.36, and above the 200-day MA of 50.79, indicating a bullish trend. The MACD of 1.79 indicates Negative momentum. The RSI at 62.87 is Neutral, neither overbought nor oversold. The STOCH value of 46.05 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CH:SKAN.

SKAN Group AG Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
YPSN	77 Outperform	CHF4.93B	22.17	27.15%	0.67%	-2.39%	154.37%
SFSN	73 Outperform	CHF5.33B	24.37	―	1.85%	0.47%	-9.20%
STMN	71 Outperform	CHF16.77B	46.76	―	1.02%	4.05%	-7.94%
TECN	59 Neutral	CHF2.35B	-20.93	4.57%	2.31%	-5.54%	-264.90%
COTN	59 Neutral	CHF3.09B	253.19	―	0.68%	2.62%	-65.24%
SKAN	57 Neutral	CHF1.28B	78.89	―	0.77%	-7.74%	-58.06%
Sector *	55 Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

SKAN Group AG Corporate Events